Renaissance Technologies’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,137,508
| Closed | -$309K | – | 4555 |
|
|
2022
Q3 | $309K | Buy |
1,137,508
+831,768
| +272% | +$363K | ﹤0.01% | 3200 |
|
|
2022
Q2 | $235K | Buy |
305,740
+186,900
| +157% | +$167K | ﹤0.01% | 3576 |
|
|
2022
Q1 | $127K | Buy |
118,840
+30,000
| +34% | +$54.5K | ﹤0.01% | 3751 |
|
|
2021
Q4 | $169K | Buy |
88,840
+39,000
| +78% | +$93.4K | ﹤0.01% | 3571 |
|
|
2021
Q3 | $150K | Sell |
49,840
-106,400
| -68% | -$379K | ﹤0.01% | 3261 |
|
|
2021
Q2 | $611K | Sell |
156,240
-439,900
| -74% | -$1.82M | ﹤0.01% | 2885 |
|
|
2021
Q1 | $3.02M | Sell |
596,140
-420,700
| -41% | -$2.18M | ﹤0.01% | 1960 |
|
|
2020
Q4 | $4.16M | Sell |
1,016,840
-52,800
| -5% | -$259K | ﹤0.01% | 1708 |
|
|
2020
Q3 | $5.2M | Sell |
1,069,640
-152,600
| -12% | -$833K | 0.01% | 1553 |
|
|
2020
Q2 | $6.77M | Sell |
1,222,240
-176,469
| -13% | -$808K | 0.01% | 1458 |
|
|
2020
Q1 | $4.59M | Buy |
1,398,709
+184,369
| +15% | +$971K | ﹤0.01% | 1618 |
|
|
2019
Q4 | $5.49M | Buy |
1,214,340
+163,280
| +16% | +$516K | ﹤0.01% | 1791 |
|
|
2019
Q3 | $4.37M | Buy |
1,051,060
+93,260
| +10% | +$337K | ﹤0.01% | 1870 |
|
|
2019
Q2 | $3.63M | Buy |
957,800
+71,200
| +8% | +$292K | ﹤0.01% | 2011 |
|
|
2019
Q1 | $3.71M | Buy |
886,600
+38,500
| +5% | +$135K | ﹤0.01% | 1994 |
|
|
2018
Q4 | $2.11M | Buy |
848,100
+140,600
| +20% | +$823K | ﹤0.01% | 2202 |
|
|
2018
Q3 | $5.17M | Buy |
707,500
+73,000
| +12% | +$320K | 0.01% | 1777 |
|
|
2018
Q2 | $2.35M | Buy |
634,500
+140,700
| +28% | +$651K | ﹤0.01% | 2185 |
|
|
2018
Q1 | $1.9M | Buy |
493,800
+49,372
| +11% | +$208K | ﹤0.01% | 2350 |
|
|
2017
Q4 | $1.6M | Buy |
444,428
+109,128
| +33% | +$412K | ﹤0.01% | 2467 |
|
|
2017
Q3 | $1.32M | Sell |
335,300
-67,884
| -17% | -$312K | ﹤0.01% | 2467 |
|
|
2017
Q2 | $2.06M | Buy |
403,184
+151,171
| +60% | +$849K | ﹤0.01% | 2250 |
|
|
2017
Q1 | $1.74M | Buy |
252,013
+199,313
| +378% | +$1.56M | ﹤0.01% | 2319 |
|
|
2016
Q4 | $493K | Sell |
52,700
-156,100
| -75% | -$1.41M | ﹤0.01% | 2765 |
|
|
2016
Q3 | $2.04M | Buy |
208,800
+89,200
| +75% | +$1.2M | ﹤0.01% | 2179 |
|
|
2016
Q2 | $1.69M | Buy |
119,600
+48,400
| +68% | +$755K | ﹤0.01% | 2301 |
|
|
2016
Q1 | $995K | Buy |
71,200
+51,200
| +256% | +$751K | ﹤0.01% | 2600 |
|
|
2015
Q4 | $408K | Buy |
+20,000
| New | +$309K | ﹤0.01% | 2800 |
|
Renaissance Technologies's AGTC Position: Q4 2022 in Review
Renaissance Technologies sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 1,137,508 shares — an estimated $309K sold.
Renaissance Technologies first reported a position in AGTC in Q4 2015 and held it in 28 quarters. The position peaked at $6.77M in Q2 2020. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Renaissance Technologies reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Renaissance Technologies sold 1,137,508 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $309K.
- Renaissance Technologies first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 28 quarters.
- Renaissance Technologies's Applied Genetic Technologies Corporation position peaked at $6.77M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.